Skip to main content

Puma Biotechnology, Inc.

PBYI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001401667

In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Puma Biotechnology, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
5 insiders, $1.12M in total
Insiders trading
5
Net value
−$1.12M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Puma Biotechnology, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Puma Biotechnology, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Wilson Troy EdwardDirector54,750Sep 16, 20262
Cesano AlessandraDirector56,700Sep 16, 20262
Auerbach Alan HPresident and CEO7,261,671Jul 8, 20263
Hunt Douglas MSee Remarks196,841Jul 8, 20263
Nougues Maximo FChief Financial Officer230,637Jul 8, 20263
Moyes Jay MDirector58,322Jun 15, 20261
Miller Michael PatrickDirector81,000Jun 15, 20262
Senderowicz AdrianDirector27,000Jun 15, 20261
Dorval AllisonDirector90,780Jun 15, 20261
Stuglik Brian MDirector113,858Jun 15, 20261
Ludwig Jeffrey JeromeChief Commercial Officer156,792Feb 11, 20250
Wong Alvin FChief Scientific Officer141,241Feb 14, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 4, 2022 (view filing)Jul 530 daysNougues Maximo FChief Financial OfficerSSale−9.33K$2.63−$24.5K−7.7%111.7K afterAmended
Aug 4, 2022 (view filing)Aug 22 daysNougues Maximo FChief Financial OfficerSSale−161$2.89−$465.29−0.1%111.6K after
Aug 10, 2022 (view filing)Aug 91 dayMiller Michael PatrickDirectorSSale−25.0K$3.55−$88.8K−31.3%54.9K after
Sep 7, 2022 (view filing)Sep 25 daysAuerbach Alan HPresident and CEOSSale−1.25K$2.59−$3.25K0.0%6.32M after
Sep 7, 2022 (view filing)Sep 25 daysHunt Douglas MSee RemarksSSale−433$2.59−$1.12K−0.6%76.9K after
Sep 7, 2022 (view filing)Sep 25 daysNougues Maximo FChief Financial OfficerSSale−164$2.59−$424.76−0.1%111.4K after
Oct 5, 2022 (view filing)Oct 32 daysAuerbach Alan HPresident and CEOSSale−1.26K$2.34−$2.95K0.0%6.31M after
Oct 5, 2022 (view filing)Oct 32 daysHunt Douglas MSee RemarksSSale−435$2.34−$1.02K−0.6%76.4K after
Oct 5, 2022 (view filing)Oct 32 daysNougues Maximo FChief Financial OfficerSSale−165$2.34−$386.1−0.1%111.2K after
Nov 4, 2022 (view filing)Nov 22 daysNougues Maximo FChief Financial OfficerSSale−163$2.25−$366.75−0.1%111.1K after
Nov 4, 2022 (view filing)Nov 22 daysAuerbach Alan HPresident and CEOSSale−1.24K$2.25−$2.79K0.0%6.31M after
Nov 4, 2022 (view filing)Nov 22 daysHunt Douglas MSee RemarksSSale−429$2.25−$965.25−0.6%76.0K after
Dec 6, 2022 (view filing)Dec 24 daysWong Alvin FChief Scientific OfficerSSale−514$4.50−$2.31K−0.9%58.0K after
Dec 6, 2022 (view filing)Dec 24 daysNougues Maximo FChief Financial OfficerSSale−159$4.50−$715.5−0.1%110.9K after
Dec 6, 2022 (view filing)Dec 24 daysHunt Douglas MSee RemarksSSale−429$4.50−$1.93K−0.6%75.6K after
Dec 6, 2022 (view filing)Dec 24 daysAuerbach Alan HPresident and CEOSSale−1.25K$4.50−$5.63K0.0%6.31M after
Jan 5, 2023 (view filing)Jan 32 daysAuerbach Alan HPresident and CEOSSale−27.2K$4.18−$113.9K−0.4%6.85M after
Jan 5, 2023 (view filing)Jan 32 daysHunt Douglas MSee RemarksSSale−4.22K$4.18−$17.7K−5.6%71.3K after
Jan 5, 2023 (view filing)Jan 32 daysLudwig Jeffrey JeromeChief Commercial OfficerSSale−6.57K$4.18−$27.5K−10.2%58.1K after
Jan 5, 2023 (view filing)Jan 32 daysNougues Maximo FChief Financial OfficerSSale−10.5K$4.18−$43.9K−9.5%100.4K after
Jan 5, 2023 (view filing)Jan 32 daysWong Alvin FChief Scientific OfficerSSale−3.46K$4.18−$14.5K−6.0%54.6K after
Jun 6, 2023 (view filing)Jun 24 daysWong Alvin FChief Scientific OfficerSSale−269$3.45−$928.05−0.2%112.9K after10b5-1
Jun 15, 2023 (view filing)Jun 132 daysMiller Michael PatrickDirectorSSale−13.5K$3.45−$46.6K−24.6%41.4K after10b5-1
Jun 15, 2023 (view filing)Jun 132 daysDorval AllisonDirectorSSale−10.0K$3.45−$34.5K−37.0%17.0K after10b5-1
Jun 15, 2023 (view filing)Jun 132 daysSenderowicz AdrianDirectorSSale−27.0K$3.45−$93.2K−100.0%0 after10b5-1
Jun 15, 2023 (view filing)Jun 132 daysStuglik Brian MDirectorSSale−9.90K$3.46−$34.3K−23.7%32.0K after10b5-1
Jun 15, 2023 (view filing)Jun 132 daysMoyes Jay MDirectorSSale−22.0K$3.45−$75.9K−57.4%16.3K after10b5-1
Jun 15, 2023 (view filing)Jun 132 daysWilson Troy EdwardDirectorSSale−27.0K$3.45−$93.2K−98.7%350 after10b5-1
Jul 6, 2023 (view filing)Jul 33 daysAuerbach Alan HPresident and CEOSSale−60.7K$3.31−$200.9K−0.9%6.98M after10b5-1
Jul 6, 2023 (view filing)Jul 33 daysHunt Douglas MSee RemarksSSale−7.81K$3.31−$25.8K−6.5%111.7K after10b5-1
Jul 6, 2023 (view filing)Jul 33 daysLudwig Jeffrey JeromeChief Commercial OfficerSSale−12.1K$3.31−$40.1K−9.7%112.9K after10b5-1
Jul 6, 2023 (view filing)Jul 33 daysNougues Maximo FChief Financial OfficerSSale−14.7K$3.31−$48.6K−9.2%144.3K after10b5-1
Jul 6, 2023 (view filing)Jul 33 daysWong Alvin FChief Scientific OfficerSSale−6.94K$3.31−$23.0K−6.1%105.9K after10b5-1
Nov 9, 2023 (view filing)Nov 72 daysMiller Michael PatrickDirectorSSale−25.0K$2.83−$70.8K−36.6%43.4K after
Jan 5, 2024 (view filing)Jan 32 daysHunt Douglas MSee RemarksSSale−8.36K$4.49−$37.5K−7.5%103.3K after10b5-1
Jan 5, 2024 (view filing)Jan 32 daysNougues Maximo FChief Financial OfficerSSale−15.7K$4.49−$70.4K−10.9%128.7K after10b5-1
Jan 5, 2024 (view filing)Jan 32 daysAuerbach Alan HPresident and CEOSSale−41.4K$4.49−$185.9K−0.6%6.94M after10b5-1
Jan 5, 2024 (view filing)Jan 32 daysLudwig Jeffrey JeromeChief Commercial OfficerSSale−13.0K$4.49−$58.2K−11.5%100.0K after10b5-1
Jan 5, 2024 (view filing)Jan 32 daysWong Alvin FChief Scientific OfficerSSale−7.73K$4.49−$34.7K−7.3%98.2K after10b5-1
Jan 10, 2024 (view filing)Dec 4, 202337 daysLateWong Alvin FChief Scientific OfficerSSale−280$3.76−$1.05K−0.3%97.9K after10b5-1
Jun 17, 2024 (view filing)Jun 134 daysDorval AllisonDirectorSSale−11.0K$3.37−$37.1K−25.0%33.0K after10b5-1
Jun 17, 2024 (view filing)Jun 134 daysMoyes Jay MDirectorSSale−22.0K$3.34−$73.5K−50.8%21.3K after10b5-1
Jun 17, 2024 (view filing)Jun 134 daysSenderowicz AdrianDirectorSSale−27.0K$3.33−$89.9K−100.0%0 after10b5-1
Jun 17, 2024 (view filing)Jun 134 daysStuglik Brian MDirectorSSale−9.90K$3.39−$33.6K−16.8%49.1K after10b5-1
Jun 17, 2024 (view filing)Jun 134 daysWilson Troy EdwardDirectorSSale−27.0K$3.33−$89.9K−98.7%350 after10b5-1
Jul 2, 2024 (view filing)Jul 2Same dayAuerbach Alan HPresident and CEOSSale−18.9K$3.27−$61.8K−0.3%7.09M after10b5-1
Jul 2, 2024 (view filing)Jul 2Same dayHunt Douglas MSee RemarksSSale−4.35K$3.27−$14.2K−3.1%136.9K after10b5-1
Jul 2, 2024 (view filing)Jul 2Same dayLudwig Jeffrey JeromeChief Commercial OfficerSSale−6.05K$3.27−$19.8K−4.8%121.0K after10b5-1
Jul 2, 2024 (view filing)Jul 2Same dayNougues Maximo FChief Financial OfficerSSale−5.29K$3.27−$17.3K−3.1%166.7K after10b5-1
Jul 18, 2024 (view filing)Jul 171 dayAuerbach Alan HPresident and CEOSSale−21.9K$3.70−$81.1K−0.3%7.06M after10b5-1